(NYSE: ZBH) Zimmer Biomet Holdings's forecast annual revenue growth rate of 5.15% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.8%.
Zimmer Biomet Holdings's revenue in 2025 is $7,833,800,000.On average, 10 Wall Street analysts forecast ZBH's revenue for 2025 to be $1,629,017,958,618, with the lowest ZBH revenue forecast at $1,623,396,588,880, and the highest ZBH revenue forecast at $1,633,043,863,301. On average, 10 Wall Street analysts forecast ZBH's revenue for 2026 to be $1,722,160,709,335, with the lowest ZBH revenue forecast at $1,694,647,752,405, and the highest ZBH revenue forecast at $1,747,800,866,832.
In 2027, ZBH is forecast to generate $1,801,155,444,875 in revenue, with the lowest revenue forecast at $1,762,107,358,796 and the highest revenue forecast at $1,848,209,778,242.